Early nerve injury treatment for throat cancer survivors
Treatments studied
Part of Brain & nervous system, Cancer, Ear, nose & throat, Injuries & trauma, Mouth & dental clinical trials.
This trial tests a medication called Ajovy (fremanezumab) to see if it can help prevent or treat early nerve damage in the tongue or throat area that can happen after treatment for throat cancer. It may help improve swallowing, speech, and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have finished treatment for throat cancer (or a related head and neck cancer) and are cancer-free.
- You have early signs of nerve damage in the tongue (shown by a special test called EMG) but no obvious symptoms yet.
- You are willing to use effective birth control during the study and for 5 months after the last dose (if applicable).
- You are able to understand and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether high-dose steroids (prednisone or methylprednisolone) can improve symptoms of nerve damage that may occur years after radiation treatment for oropharyngeal cancer. It includes a registry for tracking similar nerve issues in head and neck cancer survivors.
This study tests two medicines—pravastatin (a statin) and a combination of pentoxifylline and Vitamin E—to see if they can prevent long-term swelling (lymphedema) and scarring in the neck after radiation therapy for throat cancer. Participants receive one of the medicines daily for 2 years, and regular scans help monitor any changes.
This trial tests a new approach to treat throat cancer while trying to preserve your larynx (voice box). It combines chemotherapy drugs and an immunotherapy drug before surgery or radiation. The goal is to see if this can help you avoid needing to have your larynx removed.
This study tests an approach called “adaptive radiotherapy,” where the radiation plan may be adjusted based on how your tumor and anatomy look during treatment. It is for adults with biopsy-proven oropharyngeal (throat) squamous cell carcinoma who are planning curative radiation, with or without chemotherapy.
This trial compares two different treatments after surgery for advanced head and neck cancer (oral or oropharyngeal). It tests whether radiation therapy or continuing an immunotherapy drug (called PD-1 inhibitor) leads to better survival. This study might help you decide which follow-up treatment could be better for your situation.
This trial tests whether a procedure that disrupts the lingual nerve can help make chemotherapy and immunotherapy work better for tongue cancer before surgery. If you have advanced tongue cancer and are scheduled for this kind of treatment, this study might be a good fit.
Hear when a new Oropharyngeal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.